...Good afternoon. This is Anne Doering, Chief Financial Officer of Vivoryon. Thank you for joining us today for our R&D update webcast with key opinion leader speakers. Today's focus is on changing outcomes in kidney disease. On the call with me today is the Vivoryon Management team, including Chief Executive Officer, Frank Weber and Chief Business Officer Michael Schaeffer. Importantly, we also have key opinion leaders joining us for the presentation. Professor Tobias Huber, MD, Chair of the Center of Internal Medicine and Director of the Third Department of Medicine, University Medical Center, Hamburg-Eppendorf (UKE), Germany. He is acting as medical advisor for clinical study design and certain R&D activities. Kevin Carroll, PhD, CEO KJC Statistics. He is acting as statistical analysis expert, providing and calculating statistical readouts and advising on clinical statistical aspects. I would like to remind you that during this conference call we will present and discuss certain forward-looking...
